Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPCGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderRecruitingPhase 22024-11-26NCT05393791

3 results · Page 1 of 1

Swipe the table sideways for more columns.

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Border Medical Oncology Research Unit / The Border Cancer HospitalAlburyAustralia1
Calvary Mater NewcastleNewcastleAustralia8
Chris O'Brien LifehouseCamperdownAustralia46
Eastern Health Box HillBox HillAustralia1
Fiona Stanly HospitalMurdochAustralia1
Genesis Care North ShoreSt LeonardsAustralia4
Groene Hart ZiekenhuisGoudaNetherlands1
ICON Cancer CentreAdelaideAustralia1
Isala ZiekenhuisZwolleNetherlands1
Leids Universitair Medisch CentrumLeidenNetherlands6
Mater Hospital BrisbaneSouth BrisbaneAustralia10
Meander Medical CentreAmersfoortNetherlands1
Radboud Univeristy Medical CentreNijmegenNetherlands1
Royal Adelaide HospitalAdelaideAustralia132
Spaarne GasthuisHoofddorpNetherlands8
St George HospitalKogarahAustralia3
Sunshine Coast University HospitalBirtinyaAustralia4
Sydney Adventist HospitalWahroongaAustralia17
University Medical Center GroningenGroningenNetherlands49